Food and Drug Administration (FDA)
- Health
KFF: Nearly 3M Part D enrollees reached catastrophic drug price threshold over five-year period
Nearly 3 million enrollees in Medicare Part D spent above the catastrophic threshold at least once over a five-year period,…
Read More » - Health
CDC director: COVID-19 morphing into ‘pandemic of the unvaccinated’ as cases spike by 70%
COVID-19 cases are up by nearly 70% over the past seven days due to huge spikes of cases in low…
Read More » - Health
NYT: Cleveland Clinic, Mount Sinai won’t prescribe controversial Alzheimer’s disease drug Aduhelm
Major hospital systems Cleveland Clinic and Mount Sinai will not prescribe the pricey and controversial Alzheimer’s drug Aduhelm (aducanumab) due…
Read More » - Health
KFF: Alzheimer’s drug aducanumab could strain Medicaid budgets, too
Even with rebates, a pricey new drug to treat Alzheimer’s disease is expected to cost Medicaid more than $2 billion…
Read More » - Health
CMS starts process to decide on covering pricey Alzheimer’s drug aducanumab
The Biden administration has started to investigate whether Medicare should cover the extremely pricey Alzheimer’s drug aducanumab. The Centers for…
Read More » - Health
Executive order calls for DOJ, FTC to review hospital merger guidelines
President Joe Biden issued a sweeping executive order Friday that presses the federal government to review and revise guidelines for…
Read More »
